Richard A. Larson to Central Nervous System Diseases
This is a "connection" page, showing publications Richard A. Larson has written about Central Nervous System Diseases.
Connection Strength
0.055
-
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013. Leuk Lymphoma. 2003 Jan; 44(1):39-48.
Score: 0.055